9-133436888-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139027.6(ADAMTS13):​c.1368G>T​(p.Gln456His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00282 in 1,586,750 control chromosomes in the GnomAD database, including 130 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q456E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.015 ( 60 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 70 hom. )

Consequence

ADAMTS13
NM_139027.6 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.21

Publications

7 publications found
Variant links:
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ADAMTS13 Gene-Disease associations (from GenCC):
  • congenital thrombotic thrombocytopenic purpura
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0053318143).
BP6
Variant 9-133436888-G-T is Benign according to our data. Variant chr9-133436888-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0505 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS13NM_139027.6 linkc.1368G>T p.Gln456His missense_variant Exon 12 of 29 ENST00000355699.7 NP_620596.2 Q76LX8-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS13ENST00000355699.7 linkc.1368G>T p.Gln456His missense_variant Exon 12 of 29 1 NM_139027.6 ENSP00000347927.2 Q76LX8-2

Frequencies

GnomAD3 genomes
AF:
0.0150
AC:
2265
AN:
151396
Hom.:
60
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0525
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00490
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00816
GnomAD2 exomes
AF:
0.00362
AC:
736
AN:
203046
AF XY:
0.00260
show subpopulations
Gnomad AFR exome
AF:
0.0520
Gnomad AMR exome
AF:
0.00264
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000102
Gnomad OTH exome
AF:
0.00194
GnomAD4 exome
AF:
0.00154
AC:
2207
AN:
1435238
Hom.:
70
Cov.:
35
AF XY:
0.00127
AC XY:
904
AN XY:
711346
show subpopulations
African (AFR)
AF:
0.0536
AC:
1780
AN:
33222
American (AMR)
AF:
0.00310
AC:
126
AN:
40684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25536
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38788
South Asian (SAS)
AF:
0.0000607
AC:
5
AN:
82356
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50008
Middle Eastern (MID)
AF:
0.00314
AC:
18
AN:
5724
European-Non Finnish (NFE)
AF:
0.0000700
AC:
77
AN:
1099588
Other (OTH)
AF:
0.00339
AC:
201
AN:
59332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
112
224
335
447
559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0149
AC:
2264
AN:
151512
Hom.:
60
Cov.:
31
AF XY:
0.0148
AC XY:
1094
AN XY:
73986
show subpopulations
African (AFR)
AF:
0.0523
AC:
2160
AN:
41268
American (AMR)
AF:
0.00489
AC:
74
AN:
15120
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5118
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10472
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67946
Other (OTH)
AF:
0.00807
AC:
17
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00490
Hom.:
30
Bravo
AF:
0.0169
ESP6500AA
AF:
0.0495
AC:
216
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.00414
AC:
494
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Upshaw-Schulman syndrome Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Benign
0.91
DEOGEN2
Benign
0.36
T;T;.;.
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.58
T;T;T;T
MetaRNN
Benign
0.0053
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;.;L;.
PhyloP100
1.2
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.6
D;.;D;D
REVEL
Benign
0.088
Sift
Benign
0.072
T;.;D;D
Sift4G
Benign
0.092
T;T;T;.
Polyphen
0.0020
B;.;B;B
Vest4
0.13
MutPred
0.17
Gain of catalytic residue at L458 (P = 0.0878);.;Gain of catalytic residue at L458 (P = 0.0878);.;
MVP
0.74
MPC
0.32
ClinPred
0.023
T
GERP RS
-1.4
Varity_R
0.047
gMVP
0.68
Mutation Taster
=63/37
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36220239; hg19: chr9-136302008; API